Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Topical ophthalmic drugs].

J Delibes, F Vincent-Ballereau, M Lafleuriel

    Therapie
    |March 1, 1989
    PubMed
    Summary

    Conventional ophthalmic drugs have poor bioavailability, necessitating frequent high doses. Advanced drug delivery systems aim to improve ocular drug bioavailability but have not yet achieved satisfactory results.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [The return of diphtheria in Europe. Is the French population protected?].

    Bulletin de l'Academie nationale de medecine·1997
    Same author

    [Stability and antimicrobial effectiveness of Javel water in a tropical hospital environment].

    Bulletin de la Societe de pathologie exotique (1990)·1997
    Same author

    Diphtheria s European come back.

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·1996
    Same author

    Choice of traditional or modern treatment in west Burkina Faso.

    World health forum·1995
    Same author

    Haemophilus type B conjugate vaccine: postimmunization kinetics of IgM and IgG antibody responses in ten vaccinated children.

    Vaccine·1994
    Same author

    [Anti-Haemophilus influenzae b (Hib) natural immunity in children in Burkina Faso].

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·1994

    Area of Science:

    • Ophthalmology
    • Pharmaceutics
    • Drug Delivery Systems

    Context:

    • Topical ophthalmic drugs often exhibit poor bioavailability.
    • This necessitates frequent administration and higher drug dosages.
    • Existing advanced delivery systems have limitations.

    Purpose:

    • To review current challenges in topical ophthalmic drug delivery.
    • To discuss the limitations of existing advanced drug delivery systems.
    • To highlight the need for improved ocular drug delivery solutions.

    Summary:

    • Conventional ophthalmic medications offer limited bioavailability, requiring frequent application and higher doses.
    • Various sophisticated drug delivery systems, including inserts, lenses, liposomes, and pumps, have been developed.
    • Despite potential advantages, none of these systems have proven entirely satisfactory for ocular drug delivery.

    Impact:

    • Identifies unmet needs in ophthalmic drug delivery research.
    • Guides future development of more effective ocular drug formulations.
    • Aims to enhance therapeutic outcomes for eye conditions through improved drug bioavailability.

    Related Experiment Videos